Torrent Pharmaceuticals Ltd. | Ownership
Companies that own Torrent Pharmaceuticals Ltd.
HDFC Asset Management Co. Ltd. (Invt Mgmt)
4,908,049
2.9%
119,100
0.63%
07/31/2018
UTI Asset Management Co. Ltd. (Investment Management)
2,590,232
1.53%
56,936
0.7%
08/31/2018
SBI Funds Management Pvt Ltd.
2,185,253
1.29%
37,600
0.31%
06/30/2018
Reliance Nippon Life Asset Management Ltd. (Invt Mgmt)
1,762,013
1.04%
-259,100
0.33%
08/31/2018
HDFC Standard Life Insurance Co. Ltd. (Investment Portfolio)
1,493,401
0.88%
38,404
0.86%
07/31/2018
Fidelity Management & Research Co.
1,481,546
0.88%
707,258
0%
07/31/2018
The Vanguard Group, Inc.
1,357,313
0.8%
-8,540
0%
07/31/2018
T. Rowe Price International Ltd.
1,353,648
0.8%
0
0.06%
06/30/2018
Mirae Asset Global Investments (India) Pvt Ltd.
1,272,575
0.75%
48,259
1.33%
07/31/2018
Aditya Birla Sun Life AMC Ltd.
1,202,619
0.71%
-23,000
0.25%
07/31/2018
Address |
Torrent House Ahmedabad Gujarat 380009 India
|
Employees
|
- |
Website |
http://www.torrentpharma.com |
Updated |
09/14/2018 |
Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. It operates through India and Outside India segments. The Outside India segment includes USA, Germany, Brazil, and other countries. |